C
Clearmind Medicine Inc. (CMND)
NCM – Real Time Price. Currency in USD
0.54
+0.02 (3.81%)
At close: May 12, 2026, 4:00 PM EDT
0.56
+0.02 (3.31%)
Pre-market: May 13, 2026, 4:56 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.54
+0.02 (3.81%)
At close: May 12, 2026, 4:00 PM EDT
0.56
+0.02 (3.31%)
Pre-market: May 13, 2026, 4:56 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $9.3M significantly exceed its total debt $8.0K, ensuring strong financial flexibility
Total current assets $11.0M exceed Total current liabilities $2.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-891.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$2.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.79 | 6.05 | 10 | |
| Quick ratio | 3.79 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -891.14 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -88K | -58K | -51K | -49K | -51K |
| Operating Income | -7M | -6M | -6M | -6M | -8M |
| Net Income | -7M | -9M | -5M | -4M | -7M |
| EBITDA | -7M | -6M | -6M | -6M | -8M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -460.38 | N/A | -65.47 | 3.3 |
| Y/Y | 999 | -259.69 | N/A | -64.75 | 3.3 |
| 3y average | 999 | 15.89 | N/A | -11.1 | 5.3 |
| 5y average | 999 | -340.98 | N/A | -232.73 | 3.3 |
| Weighted average score | 3.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |